Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Vascular files patent applications.


Bio-Vascular, Inc., (St. Paul St. Paul

as a missionary he fearlessly confronts the “perils of waters, of robbers, in the city, in the wilderness.” [N.T.: II Cor. 11:26]

See : Bravery
, MN; 612-371-0000) announced that it has recently filed two United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area.  patent applications to protect new and proprietary technologies. One of these applications relates to the manufacture and use of stent coverings formed of biological tissues, and the other is for the company's new "resorbable" line of tissue implant materials.

The company continues to maintain a portfolio of patents and applications directed to its core technologies, with several applications planned to protect ongoing developments.

Bio-Vascular develops, manufactures and markets proprietary and patented specialty medical products for use in thoracic thoracic /tho·rac·ic/ (thah-ras´ik) pectoral; pertaining to the thorax (chest).

tho·rac·ic
adj.
Of, relating to, or situated in or near the thorax.
, cardiac, neuro, vascular and ophthalmic ophthalmic /oph·thal·mic/ (of-thal´mik) ocular (1).

oph·thal·mic
adj.
Of or relating to the eye; ocular.


Ophthalmic
Pertaining to the eye.
 surgery. Through the company's wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
, Jer-Neen Manufacturing Co., Inc., the company is a value-added original equipment manufacturer of micro-precision wire-based component products, including precision coils, stylets, and guidewire components and subassemblies used in the medical industry.
COPYRIGHT 1999 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Geographic Code:1USA
Date:Sep 1, 1999
Words:136
Previous Article:Diagnon announces filing of patent application entitled 'High Throughput Assay Method for Enzymes which Metabolically Hydrolyze Nucleoside...
Next Article:Avigen receives a broad patent for adeno-associated virus cancer gene therapy and a patent for adenovirus-free adeno-associated virus production.
Topics:



Related Articles
Collateral Therapeutics announces issuance of United States patent for angiogenic growth factor gene Vegf-145.
Bio-Vascular receives patent for implantable biomaterial tissue.
RTI, Osteotech announce settlement of lawsuit over bone dowel patent.
BIO-key awarded patents for biometric identification technology.
New patent suits address groundbreaking techniques.
From the benchtop to the courtroom.
BioSerae Laboratoires SA.
mNEMOSCIENCE GmbH Announces Global Licensing Agreement With Aporo Biomedical.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles